Loading institutional data...
Loading institutional data...
Held by 349 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-14
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.61B 100.0% | $1.51B 100.0% | $1.42B 100.0% | $1.48B 100.0% | $1.37B 100.0% |
| Selling, General & Admin | $158.2M 9.8% | $137.4M 9.1% | $117.4M 8.3% | $113.8M 7.7% | $101.9M 7.4% |
| Total Operating Expenses | $1.28B 79.8% | $1.19B 78.6% | $1.12B 78.9% | $1.21B 82.2% | $1.10B 79.9% |
| Operating Income | $325.8M 20.2% | $323.3M 21.4% | $300.5M 21.1% | $263.1M 17.8% | $275.7M 20.1% |
| Interest Expense | $150.4M 9.3% | $131.7M 8.7% | $114.6M 8.1% | $100.1M 6.8% | $93.7M 6.8% |
| Other Income (Expense), net | $12.1M 0.8% | $23.0M 1.5% | $15.8M 1.1% | $19.4M 1.3% | $8.3M 0.6% |
| Pretax Income | $187.6M 11.6% | $214.7M 14.2% | $201.7M 14.2% | $182.4M 12.3% | $190.3M 13.9% |
| Income Tax Expense | $6.5M 0.4% | -$9.4M -0.6% | $7.5M 0.5% | -$605K -0.0% | $3.4M 0.2% |
| Net Income | $181.1M 11.2% | $224.1M 14.8% | $194.1M 13.7% | $183.0M 12.4% | $186.8M 13.6% |
| Per Share | |||||
| EPS (Basic) | $2.95 | $3.66 | $3.22 | $3.28 | $3.61 |
| EPS (Diluted) | $2.94 | $3.65 | $3.22 | $3.25 | $3.60 |
| Weighted Avg Shares (Basic) | 61.4M | 61.3M | 60.3M | 55.8M | 51.7M |
| Weighted Avg Shares (Diluted) | 61.5M | 61.4M | 60.4M | 56.3M | 51.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $161M dividends + $0 buybacks = $161M returned on -$130M FCF.
3 consecutive years of dividend increases · 1%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 5 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 5 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $9M is below the $107M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~4.5% on $3.3B of debt.
Cash of $9M is below short-term debt of $150M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-14
No standout strengths flagged.
Where each multiple sits in its own 5-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| SG&A | 7.4 | 7.7 | 8.3 | 9.1 | 9.8 |
| Operating Income | 20.1 | 17.8 | 21.1 | 21.4 | 20.2 |
| Income Tax | 0.2 | -0.0 | 0.5 | -0.6 | 0.4 |
| Net Income | 13.6 | 12.4 | 13.7 | 14.8 | 11.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on NWE: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 95 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEV | $235.8B | 49.5× | 117.7× | 6.2× | 9.0% | 19.8% | 12.8% | 43.7% | 43.4% | 0.0× | 2,989 |
| NEE | $170.0B | 24.7× | — | 6.6× | 9.8% | — | 26.5% | 12.5% | 4.6% | — | 2,911 |
| SO | $96.0B | 22.2× | — | 3.3× | 10.6% | — | 14.7% | 12.1% | 11.8% | — | 2,268 |
| DUK | $92.6B | 18.9× | 10.7× | 2.9× | 5.6% | — | 15.7% | 9.6% | 3.7% | 5.1× | 2,360 |
| CEG | $82.5B | 35.8× | 21.7× | 3.2× | 8.3% | — | 9.1% | 16.0% | 9.9% | 2.2× | 1,836 |
| AEP | $66.1B | 18.4× | 12.9× | 3.0× | 10.9% | — | 16.9% | 11.9% | 4.8% | 5.3× | 1,854 |
| D | $56.7B | 18.7× | — | 3.4× | 14.2% | — | 18.2% | 10.3% | 3.8% | — | 1,421 |
| SRE | $54.2B | 30.2× | — | 4.0× | 3.9% | — | 13.4% | 5.8% | 5.1% | — | 1,217 |
| VST | $47.6B | 64.6× | 16.9× | 2.7× | 3.0% | — | 5.3% | 18.5% | 3.9% | 4.8× | 1,246 |
| XEL | $46.2B | 21.7× | — | — | — | — | — | 8.5% | 3.5% | — | 1,208 |
| ETR | $45.8B | 26.5× | 13.2× | 3.5× | 9.0% | — | 13.7% | 10.5% | 3.9% | 5.2× | 1,224 |
| EXC | $43.7B | — | 11.1× | 1.8× | 5.3% | — | 11.4% | 9.6% | 3.6% | 5.9× | 1,230 |
| ED | $38.2B | 18.8× | — | 2.3× | 10.9% | — | 12.0% | 8.4% | 4.0% | — | 1,368 |
| PEG | $35.3B | 16.8× | — | 2.9× | 18.3% | — | 17.3% | 12.4% | 5.3% | — | 1,231 |
| WEC | $34.2B | 21.9× | 14.7× | 3.5× | 14.0% | 66.7% | 15.9% | 11.1% | 4.5% | 5.5× | 1,310 |
| AEE | $28.7B | 19.4× | — | 3.3× | 15.4% | — | 16.6% | 10.9% | 4.5% | — | 884 |
| AWK | $27.1B | 24.4× | 10.3× | 5.3× | 10.1% | — | 21.7% | 10.3% | 8.9% | 0.6× | 1,100 |
| FE | $26.5B | 26.0× | 6.9× | 1.8× | 12.0% | — | 6.8% | 8.2% | 7.9% | 0.1× | 894 |
| ATO | $26.5B | 22.0× | 11.4× | 5.6× | 12.9% | — | 25.5% | 8.8% | 8.8% | — | 961 |
| ES | $25.7B | 15.0× | 10.0× | 1.9× | 13.8% | — | 12.5% | 10.5% | 3.8% | 5.2× | 1,012 |
| PPL | $25.4B | 21.3× | 12.4× | 2.8× | 6.9% | — | 13.1% | 7.9% | 3.5% | 5.4× | 947 |
| CNP | $25.2B | 24.2× | 12.7× | 2.7× | 8.3% | 100.0% | 11.2% | 9.4% | 3.3% | 5.8× | 774 |
| EIX | $21.6B | 4.9× | 5.8× | 1.1× | 9.8% | — | 23.1% | 25.4% | 8.0% | 3.7× | 1,005 |
| NRG | $20.7B | 27.1× | 10.0× | 0.7× | 9.2% | — | 2.8% | 51.4% | 4.8% | 5.1× | 1,010 |
| CMS | $20.5B | 18.9× | 12.8× | 2.4× | 13.6% | — | 12.5% | 11.7% | 3.8% | 6.2× | 762 |
| NWE | $4.2B | 23.4× | 13.1× | 2.6× | 6.4% | — | 11.2% | 6.3% | 2.9% | 5.8× | 349 |
Peers = companies sharing NWE's sector (Utilities) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.